Survey of diagnostic and treatment practices for multiple sclerosis in Europe

Background and purpose Up‐to‐date information is needed on the extent to which neurologists treating multiple sclerosis (MS) in Europe are integrating rapidly evolving diagnostic criteria, disease‐modifying therapies and recommendations for monitoring disease activity into their clinical practice. M...

Full description

Saved in:
Bibliographic Details
Published in:European journal of neurology Vol. 24; no. 3; pp. 516 - 522
Main Authors: Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Gionvannoni, G., Hartung, H.‐P., Havrdova, E., Kappos, L., Pozzilli, C., Soerensen, P. S., Tackenberg, B., Vermersch, P., Comi, G.
Format: Journal Article
Language:English
Published: England John Wiley & Sons, Inc 01.03.2017
Wiley
Subjects:
Adult
Clinical medicine
clinically isolated syndrome
Delphi Technique
Disease Progression
Europe
Female
Health Care Surveys
Humans
Life Sciences
Magnetic Resonance Imaging
Male
Multiple sclerosis
Multiple Sclerosis - diagnosis
Multiple Sclerosis - diagnostic imaging
Multiple Sclerosis - therapy
Multiple Sclerosis, Relapsing-Remitting - diagnosis
Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting - therapy
Neurologists
Neurons and Cognition
radiologically isolated syndrome
relapsing−remitting
Spinal Puncture
Surveys and Questionnaires
relapsing−remitting
clinically isolated syndrome
radiologically isolated syndrome
ISSN:1351-5101, 1468-1331, 1468-1331
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and purpose Up‐to‐date information is needed on the extent to which neurologists treating multiple sclerosis (MS) in Europe are integrating rapidly evolving diagnostic criteria, disease‐modifying therapies and recommendations for monitoring disease activity into their clinical practice. Methods A steering committee of MS neurologists used a modified Delphi process to develop case‐ and practice‐based questions for two sequential surveys distributed to MS neurologists throughout Europe. Case‐based questions were developed for radiologically isolated syndrome (RIS), clinically isolated syndrome (CIS), relapsing−remitting MS (RRMS) and RRMS with breakthrough disease. Results Multiple sclerosis neurologists from 11 European countries responded to survey 1 (n = 233) and survey 2 (n = 171). Respondents agreed that they would not treat the patients in the RIS or CIS cases but would treat a patient with a relatively mild form of RRMS. Choice of treatment was evenly distributed among first‐line injectables and oral treatments for mild RRMS, and moved to second‐line treatment as the RRMS case increased in severity. Additional results on RRMS with breakthrough disease are presented. Conclusions Although there was general agreement on some aspects of treatment, responses to other management and clinical practice questions varied considerably. These results, which reflect current clinical practice patterns, highlight the need for additional MS treatment education and awareness and may help inform the development of MS practice guidelines in Europe.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1351-5101
1468-1331
1468-1331
DOI:10.1111/ene.13236